Real Time PCR and digital PCR are used for specific detection and quantification of nucleic acids. The adoption of these techniques helps to measure minor variants within the genetic material. Though, real time PCR is well established technique, digital PCR delivers an absolute measure of target nucleic acid molecules. Factors such as increasing incidence & prevalence of genetic & infectious diseases; technological advancement in PCR; and rising number of CRO, forensic, and other research laboratories are driving the growth in dPCR and qPCR market. Moreover, emerging opportunities from Asian countries and transition from plant to genome based drug discovery will provide high opportunities for this market in forecast period. On the other hand, technical limitations associated with PCR and high cost of PCR devices are expected to restrict the growth of this market.
Potential of Real Time PCR and Digital PCR Market
Recently, increasing number of viral diseases put pressure on healthcare sector. For instance, according to the Centers for Disease Control and Prevention (CDC) predictions, there were only 2 Powassan virus neuroinvasive disease cases reported for the year 2008 which has increased to 33 in 2017 in the U.S. Thus, to discover the drug or biomarker for these viral diseases, researchers are widely adopting digital PCR technique. Similarly, advancement in digital PCR techniques holds great promise in detection of rare cancer biomarkers. For instance, researchers are expected to use digital droplet PCR (ddPCR) along with molecular biology techniques to discover new cancer biomarkers. Thus, such a growing advancement and rising prevalence of diseases provide huge potential for adoption of PCR techniques.
Click here to : Get Free Sample Pages of this Report
Detailed Potential Market Analysis
The dPCR and qPCR market is segmented by product (instruments, reagents & kits, consumables, and software & services), technology (qPCR, dPCR), application (clinical, research, and forensic), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research laboratories, clinical research organizations (CROs), and forensic laboratories) and geography.
Based on product, reagents and kits accounted for the largest share of dPCR and qPCR market in 2018 due to their repeated usage and rising procurement for various clinical, research, and other applications.
Based on technology, real time PCR commanded the largest share of dPCR and qPCR market in 2018. This is mainly due to increased adoption of qPCR over traditional PCR technology owing to its advantages such as fast start-up time, better temperature control, and real-time measurement. However, dPCR is expected to grow at a fastest CAGR within the forecast year due to growing preference for this technology in clinical research and drug development with absolute detection and reduced consumption of reagents.
On the basis of geographical analysis, North America including U.S. and Canada are anticipated to be the largest market due to increasing funding for qPCR and dPCR technologies, growing incidence & prevalence of infectious and genetic diseases, continuous reduction in gene sequencing cost, and presence of key players in the region. However, Asia Pacific region is expected to grow at a fastest CAGR due to rapidly developing economies, growing aging population coupled with rising incidence of genetic diseases, rise in government support for life science research, growing research & clinical trial outsourcing from the region, and increasing number of CROs.
Key Players dPCR & qPCR players
Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), bioMérieux S.A. (France), Agilent Technologies, Inc. (U.S.), Fluidigm Corporation (U.S.), Abbott Laboratories (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Meridian Bioscience, Inc. (U.S.), and Analytik Jena AG (Germany) are some of the key players in this market. The report provides the information on dPCR market share & qPCR market share of the all key players operating in this market
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
1. Introduction
1.1 Market Ecosystem
1.2 Definition
1.3 Years Considered in study
1.4 Currency And Limitations
1.5 Market Buzz and Foregrounds
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Analytics
3. Executive Summary
4. Market Insights
4.1 Drivers
4.1.1 Increasing incidences and prevalence of genetic and infectious diseases
4.1.2 Technological advancement in PCR
4.1.3 Rising number of CROs, forensic, and other research laboratories
4.2 Restraint
4.2.1 Technical limitations associated with PCR
4.2.2 High cost of PCR devices
4.3 Opportunities
4.3.1 Emerging opportunities from Asian countries
4.3.2 Transition from plant to genome based drug discovery
4.4 Challenges
4.4.1 Lack of accuracy & standardization in protocol
5. Global Digital PCR and Real-time PCR (qPCR) Market, by Product
5.1 Introduction
5.2 Instruments
5.3 Reagents & Kits
5.4 Consumables
5.4.1 Tubes
5.4.2 Plates
5.4.3 Caps & Seals
5.4.4 Others (pressure pads, racks, tray)
5.5 Software and Services
6. Global Digital PCR and Real-time PCR (qPCR) Market, by Technology
6.1 Introduction
6.2 Real Time PCR
6.3 Digital PCR
6.3.1 Droplet Digital PCR
6.3.2 BEAMing Digital PCR
7 Global Digital PCR and Real-time PCR (qPCR) Market, by Application
7.1 Introduction
7.2 Clinical
7.2.1 Pathogen Testing
7.2.2 Oncology
7.2.3 Prenatal Screening
7.2.4 Others
7.3 Research
7.3.1 Genetic Variation Analysis
7.3.2 Protein Analysis
7.3.3 miRNA and Non-Coding RNA Analysis
7.4 Forensic
8. Global Digital PCR and Real-time PCR (qPCR) Market, by End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Hospitals and Diagnostic Labs
8.4 Academic and Research Laboratories
8.5 Clinical Research Organizations (CROs)
8.6 Forensic Laboratories
9. Global Digital PCR and Real-time PCR (qPCR) Market, by Geography
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.9 RoE
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 RoAPAC
9.5 Rest of World
9.5.1 Latin America
9.5.2 Middle East & Africa
10 Competitive Landscape
10.1 Digital PCR Market Share Analysis
10.2 Real-Tim PCR (qPCR) Market Share Analysis
11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.2 F. Hoffmann-La Roche Ltd.
11.3 Bio-Rad Laboratories
11.4 QIAGEN N.V.
11.5 Agilent Technologies
11.6 bioMérieux S.A.
11.7 Danaher Corporation
11.8 Fluidigm Corporation
11.9 Takara Bio, Inc.
11.10 Abbott Laboratories
11.11 Merck KGaA
11.12 Becton, Dickinson and Company
11.13 Promega Corporation
11.14 Meridian Bioscience, Inc.
11.15 Analytik Jena AG
12. Appendix
12.1 Questionnaire
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
Published Date: Dec-2022
Published Date: Nov-2022
Published Date: Jul-2022
Published Date: Jun-2020
